TBF GENIE TISSULAIRE
TBF Génie Tissulaire is a tissue bank authorized by ANSM, established in 1992 near Lyon, France. It offers a comprehensive range of bone substitutes and regenerative solutions for clinical needs in implantology, maxillofacial surgery, ophthalmology, and dermatology. The company emphasizes safety, innovation, and ethical collaboration with medical professionals to improve patient quality of life and achieve optimal clinical results.
Industries
Nr. of Employees
small (1-50)
TBF GENIE TISSULAIRE
Products
Mineralized human bone allografts (various formats)
Mineralized, delipidated, lyophilized and gamma‑sterilized human bone allografts offered as heads/half‑heads, blocks, chips, wedges and powders for surgical bone reconstruction.
Demineralized bone matrix with endogenous growth factors
Demineralized bone matrix products processed to retain physiological bone morphogenetic proteins and collagen to provide osteoinductive and osteoconductive properties.
Combined mineralized/demineralized allografts
Composite grafts combining mineralized and demineralized bone matrices intended to leverage both structural support and osteoinductive potential.
Amniotic membrane products for ophthalmology
Viro‑inactivated, lyophilized, sterile human amniotic membrane products processed for ocular surface reconstruction and conjunctival restoration with ambient‑temperature shelf life.
Umbilical cord‑derived nerve regeneration conduit
Devitalized, virus‑inactivated, lyophilized and sterile conduit derived from umbilical cord vessels and Wharton’s jelly for peripheral nerve repair; indicated for small gaps and as a wrapping after nerve suture.
Placenta and cord wall derived membranes and parietal tissues
Processed placenta‑derived membranes and umbilical cord wall tissues treated by decellularization, viral inactivation and lyophilization for regenerative applications.
Mineralized human bone allografts (various formats)
Mineralized, delipidated, lyophilized and gamma‑sterilized human bone allografts offered as heads/half‑heads, blocks, chips, wedges and powders for surgical bone reconstruction.
Demineralized bone matrix with endogenous growth factors
Demineralized bone matrix products processed to retain physiological bone morphogenetic proteins and collagen to provide osteoinductive and osteoconductive properties.
Combined mineralized/demineralized allografts
Composite grafts combining mineralized and demineralized bone matrices intended to leverage both structural support and osteoinductive potential.
Amniotic membrane products for ophthalmology
Viro‑inactivated, lyophilized, sterile human amniotic membrane products processed for ocular surface reconstruction and conjunctival restoration with ambient‑temperature shelf life.
Umbilical cord‑derived nerve regeneration conduit
Devitalized, virus‑inactivated, lyophilized and sterile conduit derived from umbilical cord vessels and Wharton’s jelly for peripheral nerve repair; indicated for small gaps and as a wrapping after nerve suture.
Placenta and cord wall derived membranes and parietal tissues
Processed placenta‑derived membranes and umbilical cord wall tissues treated by decellularization, viral inactivation and lyophilization for regenerative applications.
Services
Tissue banking services (collection, processing, storage, distribution)
Full lifecycle services for procurement from living donors, regulated serological testing, tissue processing (inactivation, delipidation, lyophilization, sterilization), packaging and distribution to clinical users under ANSM authorization.
R&D and product development for regenerative tissue products
Development and validation of tissue processing methods and new tissue‑based therapeutic products (demineralized bone matrices, combined grafts, membranes, conduits).
Product documentation and clinical support
Provision of regulatory certificates, clinical reports, technical data sheets, instructions for use and implantation guides to support clinicians and procurement teams.
Tissue banking services (collection, processing, storage, distribution)
Full lifecycle services for procurement from living donors, regulated serological testing, tissue processing (inactivation, delipidation, lyophilization, sterilization), packaging and distribution to clinical users under ANSM authorization.
R&D and product development for regenerative tissue products
Development and validation of tissue processing methods and new tissue‑based therapeutic products (demineralized bone matrices, combined grafts, membranes, conduits).
Product documentation and clinical support
Provision of regulatory certificates, clinical reports, technical data sheets, instructions for use and implantation guides to support clinicians and procurement teams.
Expertise Areas
- Tissue banking and donor management
- Bone allograft processing and supply
- Decellularization and devitalization of human tissues
- Lyophilization and ambient‑stable tissue preservation
Key Technologies
- Lyophilization / cryo‑sublimation
- Gamma irradiation sterilization (ISO 11137)
- Chemical viral and prion inactivation processes
- Decellularization / devitalization